Literature DB >> 12829505

Tryptophan properties in fluorescence and functional stability of plasminogen activator inhibitor 1.

Stefan Verheyden1, Alain Sillen, Ann Gils, Paul J Declerck, Yves Engelborghs.   

Abstract

Plasminogen activator inhibitor 1 harbors four tryptophan residues at positions 86, 139, 175, and 262. To investigate the contribution of each tryptophan residue to the total fluorescence and to reveal the mutual interactions of the tryptophan residues and interactions with the other amino acids, 15 mutants in which tryptophan residues have been replaced by phenylalanines were constructed, purified, and characterized. Conformational distribution analysis revealed that the tryptophan mutants have a similar conformational distribution pattern as wild-type plasminogen activator inhibitor 1. Mutants in which tryptophan residue 175 was replaced by a phenylalanine displayed an increased functional half-life of the active conformation, whereas the functional half-life of mutants in which tryptophan residue 262 was replaced by a phenylalanine was substantially decreased. Comparative analysis of the fluorescence lifetimes, the extinction coefficients, and the quantum yields of the individual tryptophan residues demonstrates that tryptophan residue 262 gives the highest contribution to the total fluorescence. The other tryptophan residues have a very low quantum yield. In the wild-type protein, the fluorescence of all tryptophan residues is partially quenched as compared to the mutants that contain single tryptophan residues, due to conformational effects. The fluorescence of tryptophan residue 262 is very likely also partially quenched by energy transfer to tryptophan residue 175.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12829505      PMCID: PMC1303106          DOI: 10.1016/S0006-3495(03)74495-6

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  42 in total

1.  Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop.

Authors:  A Gils; I Knockaert; P J Declerck
Journal:  Biochemistry       Date:  1996-06-11       Impact factor: 3.162

2.  Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme.

Authors:  P A Andreasen; L S Nielsen; P Kristensen; J Grøndahl-Hansen; L Skriver; K Danø
Journal:  J Biol Chem       Date:  1986-06-15       Impact factor: 5.157

3.  Preparation and characterization of latent alpha 1-antitrypsin.

Authors:  D A Lomas; P R Elliott; W S Chang; M R Wardell; R W Carrell
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

Review 4.  Predictive value of fibrinolytic factors in coronary heart disease.

Authors:  B Wiman
Journal:  Scand J Clin Lab Invest Suppl       Date:  1999

5.  Molecular mechanics analysis of Tet repressor TRP-43 fluorescence.

Authors:  P Silvi Antonini; W Hillen; N Ettner; W Hinrichs; P Fantucci; S M Doglia; J A Bousquet; M Chabbert
Journal:  Biophys J       Date:  1997-04       Impact factor: 4.033

Review 6.  Pathophysiology of fibrinolysis.

Authors:  I Juhan-Vague; M C Alessi; P J Declerck
Journal:  Baillieres Clin Haematol       Date:  1995-06

7.  Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1.

Authors:  K Aertgeerts; H L De Bondt; C J De Ranter; P J Declerck
Journal:  Nat Struct Biol       Date:  1995-10

8.  Determination of the excited-state lifetimes of the tryptophan residues in barnase, via multifrequency phase fluorometry of tryptophan mutants.

Authors:  K Willaert; R Loewenthal; J Sancho; M Froeyen; A Fersht; Y Engelborghs
Journal:  Biochemistry       Date:  1992-01-28       Impact factor: 3.162

9.  Crystallization and X-ray diffraction data of the cleaved form of plasminogen activator inhibitor-1.

Authors:  K Aertgeerts; H L De Bondt; C De Ranter; P J Declerck
Journal:  Proteins       Date:  1995-09

10.  Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family.

Authors:  H Pannekoek; H Veerman; H Lambers; P Diergaarde; C L Verweij; A J van Zonneveld; J A van Mourik
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  5 in total

Review 1.  Utility and considerations of donor-donor energy migration as a fluorescence method for exploring protein structure-function.

Authors:  Stanislav Kalinin; Lennart B A Johansson
Journal:  J Fluoresc       Date:  2004-11       Impact factor: 2.217

2.  Metals affect the structure and activity of human plasminogen activator inhibitor-1. II. Binding affinity and conformational changes.

Authors:  Lawrence C Thompson; Sumit Goswami; Cynthia B Peterson
Journal:  Protein Sci       Date:  2011-02       Impact factor: 6.725

3.  Identification of a PAI-1-binding site within an intrinsically disordered region of vitronectin.

Authors:  Yuzhuo Chu; Joel C Bucci; Cynthia B Peterson
Journal:  Protein Sci       Date:  2019-11-20       Impact factor: 6.725

4.  The broken ring: reduced aromaticity in Lys-Trp cations and high pH tautomer correlates with lower quantum yield and shorter lifetimes.

Authors:  Azaria Solomon Eisenberg; Laura J Juszczak
Journal:  J Phys Chem B       Date:  2014-06-17       Impact factor: 2.991

5.  Probing the folding pathway of a consensus serpin using single tryptophan mutants.

Authors:  Li Yang; James A Irving; Weiwen Dai; Marie-Isabel Aguilar; Stephen P Bottomley
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.